Christopher Jaeyon Hwang, MD, MPH | |
2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517-9638 | |
(984) 974-2020 | |
Not Available |
Full Name | Christopher Jaeyon Hwang |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 9 Years |
Location | 2226 Nelson Hwy Ste 200, Chapel Hill, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063807253 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 2021-00898 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of North Carolina Hospital | Chapel hill, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
A new study in the Journal of Cell Biology identifies a cytokine signaling pathway that induces the breakdown of disused skeletal muscle. Blocking this pathway could prevent immobilized patients from losing their muscle tissue.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL).
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.
Patients wait an average of four months before seeking a cancer diagnosis, researchers report at the ESMO ASIA 2016 Congress in Singapore.
› Verified 2 days ago
Entity Name | University Of North Carolina At Chapel Hill |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
A new study in the Journal of Cell Biology identifies a cytokine signaling pathway that induces the breakdown of disused skeletal muscle. Blocking this pathway could prevent immobilized patients from losing their muscle tissue.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL).
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.
Patients wait an average of four months before seeking a cancer diagnosis, researchers report at the ESMO ASIA 2016 Congress in Singapore.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Christopher Jaeyon Hwang, MD, MPH 5221 Paramount Pkwy Ste 420, Morrisville, NC 27560-5491 Ph: () - | Christopher Jaeyon Hwang, MD, MPH 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517-9638 Ph: (984) 974-2020 |
News Archive
A new study in the Journal of Cell Biology identifies a cytokine signaling pathway that induces the breakdown of disused skeletal muscle. Blocking this pathway could prevent immobilized patients from losing their muscle tissue.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced data from its completed phase 2 clinical trial with blinatumomab in patients with B-precursor acute lymphoblastic leukemia (ALL).
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.
Patients wait an average of four months before seeking a cancer diagnosis, researchers report at the ESMO ASIA 2016 Congress in Singapore.
› Verified 2 days ago
Alexis Renee Pascoe, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 | |
Dr. Paul Singer, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4131 | |
Dr. Donald L Budenz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5151 Bioinformatics, Cb 7040, Chapel Hill, NC 27599 Phone: 919-843-0297 | |
Kathleen G Gordon, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Unc Ch Department Of Ophthalmology, 130mason Farm Rd, 5151 Bioinformatics, Chapel Hill, NC 27599 Phone: 919-966-5296 Fax: 919-966-1908 | |
Dr. Rachel A Tesser, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 55 Vilcom Center Circle, Suite 110, Chapel Hill, NC 27514 Phone: 919-960-2720 Fax: 919-960-2721 | |
Steven Brent Flynn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 |